Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Colorectal Neoplasms 82Pancreatic Neoplasms 33Stomach Neoplasms 32Rectal Neoplasms 23Colonic Neoplasms 22Neoplasms 20Neoplasm Metastasis 18Esophageal Neoplasms 16Cholangiocarcinoma 14Burkitt Lymphoma 13Adenocarcinoma Of Esophagus 13Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Carcinoma, Non-Small-Cell Lung 12Biliary Tract Neoplasms 12Adenocarcinoma 11Parkinson Disease 4, Autosomal Dominant Lewy Body 6Ovarian Neoplasms 6Gastrointestinal Neoplasms 6Leukemia, Biphenotypic, Acute 5Gallbladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Endometrial Neoplasms 5Advanced Solid Tumors 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 4Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 4Lung Neoplasms 4Leukemia 4Carcinoma, Renal Cell 4Appendiceal Neoplasms 4Urinary Bladder Neoplasms 3

Interventions

Methotrexate 2zimberelimab 1camrelizumab 1apatinib 1Specimen Handling 1Nivolumab 1Magnetic Resonance Spectroscopy 1Leucovorin 1Ipilimumab 1Drug Therapy 1Dactinomycin 1CTLA-4 Antigen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Gestational Trophoblastic Disease × Leucovorin × 1 year × Clear all
NCT04562558 2025-08-11

Biweekly Actinomycin-D Treatment or Multi-day Methotrexate Protocol in Low-risk Gestational Trophoblastic Neoplasia

Peking Union Medical College Hospital

Phase NA Active not recruiting
228 enrolled
Gynecologic

Hydatidiform Mole, Invasive, Choriocarcinoma, Gestational Trophoblastic Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡